PATENT CLAIM ANALYSIS

Application Number: 15868894
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "287000"]

Abstract:
Described herein are compounds of Formula (I) or Formula (VI), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I) or Formula (VI) and pharmaceutical compositions thereof that are mucus penetrating. Methods of using the compounds or pharmaceutical compositions thereof for treating diseases are also provided.

Claim (Index 19):
A method of treating an ocular disease comprising administering a pharmaceutical composition according to  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 86.0
- Lexical Diversity: 1.97222
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15139107', '15139099', '14181095', '15139121', '15139135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588566056470706
- 35 USC 102 Novelty (BERT): 0.5272551894437553
- Combined Prediction Score: 0.735696464026739
- Mean Citation Score: 334.706196
- Max Citation Score: 351.8019700000001
- Similarity Product: 320.6914761748744

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test